Evidence map›Paper›PMID 24944062›Full record

Trial reportThe American journal of clinical nutrition2014

Folic acid handling by the human gut: implications for food fortification and supplementation.

Imran Patanwala, Maria J King, David A Barrett, John Rose, Ralph Jackson, Mark Hudson, Mark Philo, Jack R Dainty, Anthony J A Wright, Paul M Finglas and 1 more

Open access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in The American journal of clinical nutrition, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 68 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
68citing papers in PubMed, 4 pooled it
6.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

68 citing papers in PubMed, 4 syntheses or guidelines pooled it, 136 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review

8 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 3 countries.

Imran PatanwalaInstitute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom (IP, MH, and DEJ); the Institute of Food Research, Norwich Research Park, Norwich, United Kingdom (MJK, MP, JRD, AJAW, and PMF); the Centre for Analytical Bioscience, School of Pharmacy, University of Nottingham, Nottingham, United Kingdom (DAB); and the Department of Radiology, Freeman Hospital, Newcastle upon Tyne, United Kingdom (JR and RJ).
Maria J KingInstitute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom (IP, MH, and DEJ); the Institute of Food Research, Norwich Research Park, Norwich, United Kingdom (MJK, MP, JRD, AJAW, and PMF); the Centre for Analytical Bioscience, School of Pharmacy, University of Nottingham, Nottingham, United Kingdom (DAB); and the Department of Radiology, Freeman Hospital, Newcastle upon Tyne, United Kingdom (JR and RJ).
David A BarrettInstitute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom (IP, MH, and DEJ); the Institute of Food Research, Norwich Research Park, Norwich, United Kingdom (MJK, MP, JRD, AJAW, and PMF); the Centre for Analytical Bioscience, School of Pharmacy, University of Nottingham, Nottingham, United Kingdom (DAB); and the Department of Radiology, Freeman Hospital, Newcastle upon Tyne, United Kingdom (JR and RJ).
John RoseInstitute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom (IP, MH, and DEJ); the Institute of Food Research, Norwich Research Park, Norwich, United Kingdom (MJK, MP, JRD, AJAW, and PMF); the Centre for Analytical Bioscience, School of Pharmacy, University of Nottingham, Nottingham, United Kingdom (DAB); and the Department of Radiology, Freeman Hospital, Newcastle upon Tyne, United Kingdom (JR and RJ).
Ralph JacksonInstitute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom (IP, MH, and DEJ); the Institute of Food Research, Norwich Research Park, Norwich, United Kingdom (MJK, MP, JRD, AJAW, and PMF); the Centre for Analytical Bioscience, School of Pharmacy, University of Nottingham, Nottingham, United Kingdom (DAB); and the Department of Radiology, Freeman Hospital, Newcastle upon Tyne, United Kingdom (JR and RJ).
Mark HudsonInstitute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom (IP, MH, and DEJ); the Institute of Food Research, Norwich Research Park, Norwich, United Kingdom (MJK, MP, JRD, AJAW, and PMF); the Centre for Analytical Bioscience, School of Pharmacy, University of Nottingham, Nottingham, United Kingdom (DAB); and the Department of Radiology, Freeman Hospital, Newcastle upon Tyne, United Kingdom (JR and RJ).
Mark PhiloInstitute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom (IP, MH, and DEJ); the Institute of Food Research, Norwich Research Park, Norwich, United Kingdom (MJK, MP, JRD, AJAW, and PMF); the Centre for Analytical Bioscience, School of Pharmacy, University of Nottingham, Nottingham, United Kingdom (DAB); and the Department of Radiology, Freeman Hospital, Newcastle upon Tyne, United Kingdom (JR and RJ).
Jack R DaintyInstitute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom (IP, MH, and DEJ); the Institute of Food Research, Norwich Research Park, Norwich, United Kingdom (MJK, MP, JRD, AJAW, and PMF); the Centre for Analytical Bioscience, School of Pharmacy, University of Nottingham, Nottingham, United Kingdom (DAB); and the Department of Radiology, Freeman Hospital, Newcastle upon Tyne, United Kingdom (JR and RJ).
Anthony J A WrightInstitute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom (IP, MH, and DEJ); the Institute of Food Research, Norwich Research Park, Norwich, United Kingdom (MJK, MP, JRD, AJAW, and PMF); the Centre for Analytical Bioscience, School of Pharmacy, University of Nottingham, Nottingham, United Kingdom (DAB); and the Department of Radiology, Freeman Hospital, Newcastle upon Tyne, United Kingdom (JR and RJ).
Paul M FinglasInstitute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom (IP, MH, and DEJ); the Institute of Food Research, Norwich Research Park, Norwich, United Kingdom (MJK, MP, JRD, AJAW, and PMF); the Centre for Analytical Bioscience, School of Pharmacy, University of Nottingham, Nottingham, United Kingdom (DAB); and the Department of Radiology, Freeman Hospital, Newcastle upon Tyne, United Kingdom (JR and RJ).
David E JonesInstitute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom (IP, MH, and DEJ); the Institute of Food Research, Norwich Research Park, Norwich, United Kingdom (MJK, MP, JRD, AJAW, and PMF); the Centre for Analytical Bioscience, School of Pharmacy, University of Nottingham, Nottingham, United Kingdom (DAB); and the Department of Radiology, Freeman Hospital, Newcastle upon Tyne, United Kingdom (JR and RJ).
University of Nottingham · GBNorwich University · USFreeman Hospital · GBNewcastle University · GB

Funding

Yale University Clinical and Translational Science Award ProgramUL1TR000142 · NCATS · YALE UNIVERSITY · PI SHERWIN, ROBERT S · 2012 to 2015
$31.8M
Biotechnology and Biological Sciences Research Council BB/F012594/1Biotechnology and Biological Sciences Research Council BB/F014104/1Biotechnology and Biological Sciences Research Council BB/F014457/1Biotechnology and Biological Sciences Research Council BB/FO14457/1NCATS NIH HHS UL1 TR000142
6 · The paper itself

Abstract

backgroundCurrent thinking, which is based mainly on rodent studies, is that physiologic doses of folic acid (pterylmonoglutamic acid), such as dietary vitamin folates, are biotransformed in the intestinal mucosa and transferred to the portal vein as the natural circulating plasma folate, 5-methyltetrahydrofolic acid (5-MTHF) before entering the liver and the wider systemic blood supply.

objectiveWe tested the assumption that, in humans, folic acid is biotransformed (reduced and methylated) to 5-MTHF in the intestinal mucosa.

designWe conducted a crossover study in which we sampled portal and peripheral veins for labeled folate concentrations after oral ingestion with physiologic doses of stable-isotope-labeled folic acid or the reduced folate 5-formyltetrahydrofolic acid (5-FormylTHF) in 6 subjects with a transjugular intrahepatic porto systemic shunt (TIPSS) in situ. The TIPSS allowed blood samples to be taken from the portal vein.

resultsFifteen minutes after a dose of folic acid, 80 ± 12% of labeled folate in the hepatic portal vein was unmodified folic acid. In contrast, after a dose of labeled 5-FormylTHF, only 4 ± 18% of labeled folate in the portal vein was unmodified 5-FormylTHF, and the rest had been converted to 5-MTHF after 15 min (postdose).

conclusionsThe human gut appears to have a very efficient capacity to convert reduced dietary folates to 5-MTHF but limited ability to reduce folic acid. Therefore, large amounts of unmodified folic acid in the portal vein are probably attributable to an extremely limited mucosal cell dihydrofolate reductase (DHFR) capacity that is necessary to produce tetrahydrofolic acid before sequential methylation to 5-MTHF. This process would suggest that humans are reliant on the liver for folic acid reduction even though it has a low and highly variable DHFR activity. Therefore, chronic liver exposure to folic acid in humans may induce saturation, which would possibly explain reports of systemic circulation of unmetabolized folic acid.

Indexed as

Dietary SupplementsFood, FortifiedAdministration, OralAdultBiotransformationCarbon RadioisotopesCohort StudiesCross-Over StudiesFemaleFolic AcidHumansIntestinal MucosaKineticsLeucovorinMaleMethylation5-methyltetrahydrofolateCarbon RadioisotopesFolic AcidLeucovorinTetrahydrofolates

Identifiers

PMID24944062
PMCPMC4095662
OpenAlexW2105957834

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.